Suppr超能文献

《COVID-19 疫情:瑞典斯德哥尔摩血液透析和腹膜透析患者的管理和结局》

The COVID-19 Epidemic: Management and Outcomes of Hemodialysis and Peritoneal Dialysis Patients in Stockholm, Sweden.

机构信息

Department of Renal Medicine, Danderyd Hospital, Stockholm, Sweden.

Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

出版信息

Kidney Blood Press Res. 2021;46(2):250-256. doi: 10.1159/000514268. Epub 2021 Mar 26.

Abstract

BACKGROUND

The COVID-19 outbreak has been associated with a high morbidity, mortality, and a risk of long-term sequelae, and patients with severe COVID-19 are at increased risk of acute kidney injury. CKD patients are at high risk of being exposed to COVID-19 and suffer complications and poor outcome. In Sweden, mitigation strategies did not include lockdown. During March-April of 2020, wide-spread infection occurred in Stockholm.

METHODS

Management and outcomes in forty hemodialysis (HD) patients and 4 peritoneal dialysis (PD) patients, with symptomatic COVID-19 in greater Stockholm during March and April of 2020 are reported.

RESULTS

Twenty-four HD patients (60%) required medical care and hospitalization, whereas 16 patients (40%) were treated at home. Nine patients died (mortality rate of 22.5%), of whom 8 were men. The median age in non-survivors (78 years) was significantly higher than in survivors (p = 0.003). The median time in dialysis (11.5 years) was also significantly longer in non-survivors (p = 0.01). C-reactive protein (CRP) at diagnosis in 7 of non-survivors (median 213 mg/L, range 86-329 mg/L) was significantly higher than the CRP in 25 survivors (median 87 mg/L, range 1-328 mg/L) (p = 0.0003). Maximum CRP also indicated poorer outcome among hospitalized patients (p = 0.0004). The gender imbalance was striking with only men dying apart from 1 elderly woman. Only 4 PD patients were hospitalized with symptomatic COVID-19. One patient died, 2 were discharged, and 1 was treated at the intensive care unit and survived.

CONCLUSION

HD patients >70 years were reported with longer dialysis vintage, higher CRP, and males were at an increased risk of dying from COVID-19, whereas those <70 years seemed to have a milder disease. Mitigation strategies to reduce rates of infection in high-risk populations remain essential. Follow-up focusing on long-term prognosis for extrapulmonary manifestations is likely to be important also in dialysis patients.

摘要

背景

COVID-19 疫情发病率、死亡率高,并存在长期后遗症风险,重症 COVID-19 患者发生急性肾损伤的风险增加。CKD 患者感染 COVID-19 风险高,并发症多,预后不良。瑞典未采取封锁等缓解策略。2020 年 3-4 月,斯德哥尔摩广泛传播感染。

方法

报告了 2020 年 3-4 月斯德哥尔摩地区症状性 COVID-19 的 40 名血液透析(HD)患者和 4 名腹膜透析(PD)患者的管理和结局。

结果

24 名 HD 患者(60%)需要医疗和住院治疗,16 名患者(40%)在家治疗。9 名患者死亡(死亡率 22.5%),其中 8 名男性。非幸存者(78 岁)的中位年龄明显高于幸存者(p = 0.003)。非幸存者的中位透析时间(11.5 年)也明显长于幸存者(p = 0.01)。7 名非幸存者(中位数 213mg/L,范围 86-329mg/L)的 C 反应蛋白(CRP)在诊断时明显高于 25 名幸存者(中位数 87mg/L,范围 1-328mg/L)(p = 0.0003)。住院患者的 CRP 最大值也表明预后较差(p = 0.0004)。性别失衡显著,除了一名老年妇女外,只有男性死亡。仅有 4 名 PD 患者因症状性 COVID-19 住院。1 名患者死亡,2 名患者出院,1 名患者在重症监护病房接受治疗并存活。

结论

报告了年龄>70 岁的 HD 患者,透析时间较长,CRP 较高,男性感染 COVID-19 死亡风险增加,而年龄<70 岁的患者疾病似乎较轻。减少高危人群感染率的缓解策略仍然至关重要。关注透析患者肺外表现的长期预后可能也很重要。

相似文献

5
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.

引用本文的文献

本文引用的文献

1
Membranous nephropathy associated with viral infection.与病毒感染相关的膜性肾病。
Clin Kidney J. 2020 Apr 15;14(3):876-883. doi: 10.1093/ckj/sfaa026. eCollection 2021 Mar.
4
AKI in Hospitalized Patients with COVID-19.COVID-19 住院患者中的急性肾损伤。
J Am Soc Nephrol. 2021 Jan;32(1):151-160. doi: 10.1681/ASN.2020050615. Epub 2020 Sep 3.
7
Treatment impact on COVID-19 evolution in hemodialysis patients.治疗对血液透析患者新冠病毒肺炎病情演变的影响
Kidney Int. 2020 Oct;98(4):1053-1054. doi: 10.1016/j.kint.2020.07.010. Epub 2020 Aug 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验